Peer Review History

Original SubmissionJuly 5, 2022
Decision Letter - Ricardo Toshio Fujiwara, Editor, Bruce A. Rosa, Editor
Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

Dear Pham,

Thank you very much for submitting your manuscript "Effects of Helminths and Anthelmintic Treatment on Cardiometabolic Diseases and Risk Factors: A Systematic Review" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.

Reviewers have provided generally positive feedback. A couple of important suggestions are to make a more clear separation of human and animal studies, and to include some of the important relevant findings for worms outside of the top 10 most prevalent in human infections. Two different reviewers also suggest citing some existing related review papers, which would help provide some context for the novelty of this review.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Bruce A. Rosa

Academic Editor

PLOS Neglected Tropical Diseases

Ricardo Fujiwara

Section Editor

PLOS Neglected Tropical Diseases

***********************

Reviewers have provided generally positive feedback. A couple of important suggestions are to make a more clear separation of human and animal studies, and to include some of the important relevant findings for worms outside of the top 10 most prevalent in human infections. Two different reviewers also suggest citing some existing related review papers, which would help provide some context for the novelty of this review.

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: (No Response)

Reviewer #2: No new analysis required; all well done. No Ethical issues.

Reviewer #3: Yes

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: (No Response)

Reviewer #2: Yes

Reviewer #3: Yes

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: (No Response)

Reviewer #2: Refer my general comment

Reviewer #3: Yes

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: (No Response)

Reviewer #2: Minor revision

Reviewer #3: Please refer to comments attached.

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: This manuscript aims to provide a systematic assessment of the causal relationship between helminth infection and cardiometabolic diseases and the effect of helminth eradication on

cardiometabolic risk. The analysis of 83 papers led to the conclusion that helminth infection may offer protection against dyslipidemia, metabolic syndrome, diabetes, and atherosclerotic cardiovascular disease, and that this protection may lessen after anthelmintic treatment.

A standard approach for the selection of manuscripts for the systematic review was adopted – however, it seems that only a small number of parasites were included in the search criteria. While this was justified by the authors through the claim that these were the top ten most prevalent in human infections, I think this is an important fact, which may have skewed the collection of research data. Therefore, I think this selection approach should be clearly stated in the abstract of the manuscript.

For each medical criteria a comprehensive comparison has been made with the effect of helminth infection. However, in terms of assessing the effect of helminth infection, I would prefer to see some delineation between the animal and human studies – these should not be grouped as a collective for the determination of efficacy of helminth infection. The animal studies are all experimental infections which typically use higher doses than are ever found in endemic human single infections. Furthermore, the infection progression is more defined in the animal studies, whereas the human population are deemed infected in this review if they present with a positive antigen test – although this does not mean that they are actually actively infected.

The discussion was well considered and raised the interesting prospect that there may be non-immune effects of helminth infection which are mediating the protective effect that is seen in disease.

However, I was surprised that the authors did not mention or refer to the recent systematic review which assessed the association of helminth infection with the metabolic syndrome and diabetes (doi: 10.3389/fendo.2021.728396.) – this should be considered in their discussion in comparison the findings presented here.

Reviewer #2: The study by Pham et al addressed a pertinent issue in their comprehensive systematic review which aimed to assess the reported effects of helminth infections and antihelminthic treatment on the development and/or severity of cardiometabolic diseases and risk factors. After analyzing 83 animal and human studies, the authors concluded that helminth infection may offer protection against dyslipidemia, metabolic syndrome, diabetes, and atherosclerotic cardiovascular disease. Overall, the manuscript is well written and can be further enriched by addressing the following comments:

1. Method: Clarify the statement "search was updated on March 1, 2022" versus data bases included until March 02, 2022.

2. Introduction: a bit shallow; better to show existing inconsistency in the literature though several studies favor inverse association between helminth infections and metabolic syndrome.

3. General questions on the discussion: Different helminths modulate the immune system differently and hence their effect varies. Besides, their effect could differ during acute and chronic infections with the typical example of schistosomiasis where infection with S mansoni for example induces production of both pro-inflammatory and anti-inflammatory as well as regulatory cytokines during acute and chronic infections, respectively. Did authors notice any difference between those studies which demonstrated inverse association versus those which didn’t in terms of chronicity of helminthic infections? Have authors noticed any common feature or limitation among those studies which reported the reverse or found no difference between infection and cholesterol level for example?

4. Authors suggested non-immunological mechanisms/other metabolic mechanisms could explain the protective role of helminth infections based on their observation of the lack of association with hsCRP levels. Although CRP is an acute phase reactant and marker of inflammation, will it be valid to exclude immunological mechanisms without looking into the other immunological markers? It is very true that one of the key roles of the liver is lipid and glucose metabolism; however, this same organ is the source of many of the cytokines including those that affect the metabolic functions of the liver. Given the cross-sectional nature of the studies, establishing causal relationship might be difficult and the metabolic mechanisms suggested by authors (which are not explained) have to be considered without excluding immunological causes

5. Finally, given the fact that WHO recommends periodic deworming to all at-risk people living in endemic areas, what will be the implications of the findings? Considering the protective role of helminthic infections can we recommend differently or where shall we strike the balance between keeping our old day worms and hence benefit from their co-existence versus their elimination (keeping in mind their bad side)?

6. Minor: please check reference listing format of the journal, some contain month. In addition, there are paragraphs/sentences throughout the document where reviewed studies’ findings are mentioned but with no references cited.

Other than these issues, this is an excellent comprehensive systematic review which revisits "the Hygiene hypothesis" with a different perspective.

Thank you

Reviewer #3: Please refer to comments attached.

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Aster Tsegaye

Reviewer #3: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

References

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article's retracted status in the References list and also include a citation and full reference for the retraction notice.

Attachments
Attachment
Submitted filename: PLOS NTDs review notes_12sep22.docx
Revision 1

Attachments
Attachment
Submitted filename: PLOS NTD SR--Response to Reviewers_FINAL.docx
Decision Letter - Ricardo Toshio Fujiwara, Editor, Bruce A. Rosa, Editor

Dear Pham,

We are pleased to inform you that your manuscript 'Effects of Helminths and Anthelmintic Treatment on Cardiometabolic Diseases and Risk Factors: A Systematic Review' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Bruce A. Rosa

Academic Editor

PLOS Neglected Tropical Diseases

Ricardo Fujiwara

Section Editor

PLOS Neglected Tropical Diseases

***********************************************************

The authors have addressed all reviewer concerns. The clearer separation of human and animal studies, both in the text and in the tables has substantially improved the flow of the manuscript and it will now serve as a more useful resource for readers.

Formally Accepted
Acceptance Letter - Ricardo Toshio Fujiwara, Editor, Bruce A. Rosa, Editor

Dear Pham,

We are delighted to inform you that your manuscript, "Effects of Helminths and Anthelmintic Treatment on Cardiometabolic Diseases and Risk Factors: A Systematic Review," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .